As the demand for app-based services grows, now may be the time to invest in UX research to identify needed improvements and enhancements.
Back to team page
Stephanie Wiltman
Senior UX Researcher
Stephanie has a unique interdisciplinary research background in biomechanics, behavioral psychology, and medical grade plastics. She also has variety of experience in imaging and spectroscopy devices. To each project Stephanie brings the integration of engineering and behavioral psychology to explore creative product insights and improve quality of life. She has published peer reviewed research and presented at national and international conferences. Stephanie has a PhD in Bioengineering from the University of Pittsburgh and a BS in Materials Science and Engineering and a BS in Psychology from Virginia Tech.
Bold facts
Learn more about
Something unique about you summed up in one sentence
Your favorite part of working at Bold Insight
In your spare time (or if you had spare time), you would absolutely do this:
Long-term personal or professional goal?
You cannot start the day without doing this:
Your ultimate celebrity dinner party guest list would include:
Your favorite city in the world is...and why?
Any other facts to share?
- Bold Insight and Eli Lilly and Company co-publish journal article on novel assessment tool to enhance medical device usability
- Integrating AI with care: FDA reveals focus areas for forthcoming guidance on AI products
- Bold Insight to launch AI research project at the 2024 HFES Health Care Symposium
- Bold Insight to present on IFU design, digital telemetry, and other human factors topics at HFES Healthcare Symposium
- Bold Insight to present on global medical device testing, in-person research logistics during COVID at HFES Health Care Symposium
Read our team’s latest bold insights
Human factors research in the times of COVID
Human factors research in the support of medical and drug delivery device commercialization is essential and we should be planning on a return to in-person research as soon as is possible by applying all available and practical protective measures.
COVID-19: Using human factors and UX to make a positive impact
We have aggregated some considerations for HCPs, healthcare organizations, and others involved in the medical space.
Is FMEA inadequate for human factors analyses?
A “traditional” risk assessment does not meet the needs of FDA-required human factors analyses.